AU8760298A - Coup-tfi directed therapies in the treatment of disease - Google Patents

Coup-tfi directed therapies in the treatment of disease

Info

Publication number
AU8760298A
AU8760298A AU87602/98A AU8760298A AU8760298A AU 8760298 A AU8760298 A AU 8760298A AU 87602/98 A AU87602/98 A AU 87602/98A AU 8760298 A AU8760298 A AU 8760298A AU 8760298 A AU8760298 A AU 8760298A
Authority
AU
Australia
Prior art keywords
tfi
coup
disease
treatment
directed therapies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87602/98A
Inventor
Fredrick A. Pereira
Yuhong Qiu
Ming-Jer Tsai
Sophia Y. Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU8760298A publication Critical patent/AU8760298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU87602/98A 1997-08-01 1998-07-31 Coup-tfi directed therapies in the treatment of disease Abandoned AU8760298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5508397P 1997-08-01 1997-08-01
US60055083 1997-08-01
PCT/US1998/015737 WO1999006034A1 (en) 1997-08-01 1998-07-31 Coup-tfi directed therapies in the treatment of disease

Publications (1)

Publication Number Publication Date
AU8760298A true AU8760298A (en) 1999-02-22

Family

ID=21995472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87602/98A Abandoned AU8760298A (en) 1997-08-01 1998-07-31 Coup-tfi directed therapies in the treatment of disease

Country Status (2)

Country Link
AU (1) AU8760298A (en)
WO (1) WO1999006034A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1471926E (en) 1999-06-01 2011-03-11 Baylor College Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
US7053200B1 (en) 1999-06-01 2006-05-30 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
AU2009280769B2 (en) * 2008-08-13 2014-09-18 Keio University Agent for promoting neuronal differentiation and method therefor
TWI710635B (en) 2014-10-09 2020-11-21 美商珍維克公司 Adenoviral vector encoding human atonal homolog-1 (hath1)

Also Published As

Publication number Publication date
WO1999006034A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
EP1015578A4 (en) Therapeutic molecules
AU7378198A (en) Therapeutic ultrasound system
AU2508597A (en) Drug for the treatment of tumours
AU1184399A (en) Therapeutic molecules
AU2418499A (en) Org-5222 in the treatment of depression
AU3351495A (en) Massage mat
HK1025954A1 (en) Triptolide derivatives useful in the treatment of autoimmune diseases
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6300898A (en) Well treatment with particles
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU8760298A (en) Coup-tfi directed therapies in the treatment of disease
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU1171099A (en) Therapeutic agents
AUPM885894A0 (en) Therapeutic molecules
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU2713797A (en) Depigmentating agent in the treatment of melasma
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
AU1801297A (en) Spiro-ketal derivatives and their use as therapeutic agents
AU6404698A (en) Treatment methods for obtaining therapeutic products and resulting products
AU6409598A (en) An improvement in the treatment of wastes
AUPO511797A0 (en) Therapeutic and diagnostic agents-II
AUPP017497A0 (en) Therapeutic and diagnostic agents
AUPO314896A0 (en) Therapeutic agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase